Table of Contents

Preface

Immunotherapy is expected to be the ultimate nemesis of malignant glioma PDF
Xue⁃jun YANG 71-72

Advance of Immune Study in Brain Glioma

Regulation of tumor immunity by metabolism of glioma cells and immune cells in tumor microenvironment PDF
Yi⁃ming ZHANG, Sheng⁃ping YU, Pei⁃dong LIU, Tao LI, Liang ZHANG, Yang XIE, Jia⁃bo LI, Jin⁃hao ZHANG, Xiao⁃guang FAN, Xue⁃jun YANG 73-78
Trends and developments in translational immunotherapy of brain tumors PDF
Peng⁃hao LIU, Yu WANG, Wen⁃bin MA 79-85
Immunotherapy targeting glioma stem cells and its microenvironment PDF
Hai⁃yang WANG, Jun DONG 86-95
Advance of immune checkpoint inhibitors and clinical trials in glioma PDF
Xiao⁃jie DING, Di CHEN, Chao TANG, Yu YAO 96-104
Clinical advances on chimeric antigen receptor T cell therapy for glioblastoma PDF
Jun CAO, Ye CHENG, Te⁃er BA, Feng LING, Qing⁃tang LIN 105-110
Oncolytic viruses for the treatment of malignant glioma PDF
Hong⁃yu LIU, Xin⁃guang YU, Ling CHEN 111-118
The application of dendritic cells vaccination in malignant glioma PDF
Hong⁃yu LIU, Shao⁃ping SHEN, Lin YANG, Xin⁃guang YU, Ling CHEN 119-126
The influence of radiotherapy on the immune status of glioblastoma PDF
Meng⁃lin NIE, Xiao⁃guang QIU 127-135
Immune⁃related diseases in neurosurgery PDF
Lei CHEN, Xue⁃jun YANG 136-139


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

ISSN: 1672-6731